Prof. Xiaozhou Mou | Pharmaceutical Science | Best Researcher Award
Professor | Zhejiang Provincial People’s Hospital | China
Prof. Xiao-Zhou Mou, Ph.D., is a distinguished scientist and academic leader specializing in translational medicine, cancer immunotherapy, and nanomedicine. He currently serves as Professor, Associate Director, and Team Leader at the Clinical Research Institute of Zhejiang Provincial People’s Hospital, affiliated with Hangzhou Medical College, where he leads multidisciplinary research programs advancing innovative therapies for cancer and inflammatory diseases. He also holds academic affiliations with the School of Pharmacy at Hangzhou Medical College and the College of Life Science at Zhejiang Chinese Medical University. Prof. Mou earned his Bachelor of Science in Food Science and Biotechnology at Zhejiang Gongshang University, pursued his Ph.D. in Medicine at Zhejiang University under esteemed mentors, and completed postdoctoral training in surgical oncology at Zhejiang University’s First Affiliated Hospital. His professional journey includes academic leadership, clinical translational research, and pioneering work in nanomedicine, where he developed nanovesicle- and virus-based therapeutic systems. His research interests span nanomedicine, cancer immunotherapy, gene therapy, stem cell biology, and regenerative medicine, with projects ranging from glioblastoma therapy to plant-derived nanovesicle treatments for inflammatory diseases. He has published 187 documents with 6,177 citations by 5,819 documents, achieving an h-index of 39, reflecting the significant impact of his research. Widely recognized for his groundbreaking contributions, he has secured national and provincial grants and established strong international collaborations. His excellence has been acknowledged through prestigious honors such as Outstanding Young Scholar of Zhejiang Province, Innovative Talent in the Medical Field, and multiple youth talent training awards, underscoring his reputation as a rising leader in biomedical research. With a commitment to mentoring young scientists and bridging basic science with clinical applications, Prof. Mou continues to drive forward next-generation therapeutic strategies that improve patient outcomes and shape the future of cancer and regenerative medicine.
Featured Publications
Mou, X.-Z., Li, Y., Zhang, H., & Chen, J. Honeysuckle-derived nanovesicles for the treatment of inflammatory and metabolic diseases. Nano Research, 16(4), 1123–1138.
Mou, X.-Z., Wang, L., Zhou, Y., & Xu, Q. Bio-barrier-adaptable biomimetic nanomedicines for enhanced cancer therapy. Advanced Science, 9(15), 2201347.
Mou, X.-Z., Chen, R., Huang, P., & Zhao, T. Multifunctional nanoparticles for tumor immunotherapy. ACS Nano, 15(12), 19234–19245.
Mou, X.-Z., & Zhang, Y. Engineered exosome-like vesicles as next-generation nanomedicines. Signal Transduction and Targeted Therapy, 5(1), 123.
Mou, X.-Z., Yang, D., & Liu, F. Oncolytic virus-based nanomedicine for cancer immunotherapy. Cancer Immunology Research, 7(8), 1345–1356.